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Background and Objectives Paediatric blood transfusion for severe anaemia in
hospitals in sub-Saharan Africa remains common. Yet, reports describing the
haematological quality of donor blood or storage duration in routine practice are
very limited. Both factors are likely to affect transfusion outcomes.
Materials and Methods We undertook three audits examining the distribution of
pack types, haematological quality and storage duration of donor blood used in a
paediatric clinical trial of blood at four hospitals in Africa (Uganda and Malawi).
Results The overall distribution of whole blood, packed cells (plasma-reduced by
centrifugation) and red cell concentrates (RCC) (plasma-reduced by gravity-depen-
dent sedimentation) used in a randomised trial was 407% (N = 1215), 224%
(N = 669) and 368% (N = 1099), respectively. The first audit found similar med-
ian haematocrits of 570% (500,740), 640% (520,725; P = 0238 vs. whole
blood) and 560% (480,670; P = 0462) in whole blood, RCC and packed cells,
respectively, which resulted from unclear pack labelling by blood transfusion ser-
vices (BTS). Re-training of the BTS, hospital blood banks and clinical teams led to,
in subsequent audits, significant differences in median haematocrit and haemoglo-
bins across the three pack types and values within expected ranges. Median stor-
age duration time was 12 days (IQR: 6, 19) with 182% (537/2964) over 21 days in
storage. Initially, 9 (28%) packs were issued past the recommended duration of
storage, dropping to 03% (N = 7) in the third audit post-training.
Conclusion The study highlights the importance of close interactions and educa-
tion between BTS and clinical services and the importance of haemovigilance to
ensure safe transfusion practice.
Key words: anaemia, blood transfusion services, donor blood pack, haematocrit,
haemoglobin.
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Introduction
The availability of safe blood for transfusion is funda-
mental for every healthcare system. Quality-assurance
practices are a legal requirement for blood transfusion
services (BTS) in high-income countries to minimize
patient risk. Yet, even within this context the prolonged
storage of donor blood remains controversial [1–3], since
transfusions given to critically ill patients with longer
storage age have resulted in unintended, adverse conse-
quences [1, 4, 5]. In sub-Saharan Africa (sSA), where the
demand for transfusion is high, little research has been
conducted on the quality and safety of donor blood or
how these effect post-transfusion outcomes. With regard
to the safety of blood, most studies or reviews have
focused on the risks of transfusion-transmitted infections
(TTIs) [6], with a smaller number investigating the micro-
biological hazards [7]. To our knowledge, no previous
studies have been conducted within sSA that have inves-
tigated the haematological quality or storage age of
donor blood under routine operational conditions.
Children are the main recipients of blood transfusions
in sSA, where severe anaemia remains a leading cause of
both admission to hospital and of direct mortality [8],
and is a major factor in the estimated 600 000 malaria
deaths each year [9]. We are currently investigating the
impact of the World Health Organization (WHO) transfu-
sion guidelines on within-hospital and post-discharge
paediatric survival in a multicentre phase III clinical trial
entitled Transfusion and Treatment of Severe Anaemia in
African Children: a randomised controlled Trial (TRACT;
ISRCTN 84086586) [10]. TRACT is being conducted at
four hospitals in sSA: three in Uganda (Mulago National
Referral Hospital (NRH) and the Mbale and Soroti Regio-
nal Referral Hospitals (RRH)) and at one hospital in
Malawi (Queen Elizabeth Central Hospital in Blantyre).
One intervention that TRACT is investigating is a higher
vs. a standard volume of transfused blood (calculated in
millilitres per kilogram of the child’s bodyweight). In the-
ory, the volume of blood given should translate to a pre-
dictable red cell mass being transfused. However, we were
unable to find any data on haematological quality control
to support this assumption in the settings where the trial
was being conducted. Moreover, a further challenge to
implementing a protocol to ensure clear separation
between the two transfusion volume strategies was that
BTS supplied three different pack types: whole blood, red
cell concentrates (RCC) and packed cells (Fig. 1). We also
investigated the storage age of the blood, that is the time
from donation to blood transfusion, as concerns have
been raised about the quality of blood stored beyond
23 days (‘old blood’) [11, 12] even when blood is leuco-
cyte-reduced and storage is quality-assured. In most
countries, in sSA donated blood is not leucocyte-reduced
during its processing and maintaining a cold-chain is
often a challenge [13].
Here, we report the results of audits conducted at dif-
ferent time points during the TRACT trial to investigate
the haematological quality and storage duration of donor
blood packs provided by BTS at the four trial centres at
three time points during the course of the TRACT trial. In
addition, in order for practising clinicians to be better
informed about the transfusions they regularly prescribe
we also include a description of processes of preparation
of the different pack types available for transfusion,
which were integral to the interpretation of the findings
of our audits.
Materials and methods
In Uganda, the processing and supply of donor packs to
Mulago NRH were done by Nakasero National BTS while
Mbale and Soroti RRHs received supplies from Mbale
Regional BTS. In Malawi, Blantyre Regional BTS pro-
cessed and supplied blood to Queen Elizabeth Central
Hospital.
Quality assurance
The haemoglobin and haematocrit values of all donor
blood packs were verified within the trial using an ali-
quot, collected from the blood line prior to the start of
each transfusion. In order to accurately calculate volumes
of blood received by children in the trial, all donor packs
were weighed before transfusion. The packs were then
gently agitated until well-mixed before being run into a
gauged (and filtered) ‘burette giving-set’ and then
through the infusion line to the intravenous infusion or
giving-set. The first few drops of blood released from the
giving-set were collected under sterile conditions into a
2 ml apex tubes before infusion lines were connected to
patients’ cannulae. Haemoglobin values were measured at
the bedside using the HemoCue Hb301 system (HemoCue
AB, Angelholm, Sweden), quality-controlled with Eurotrol
Hb301 Control reagents (Eurotrol, Ede, the Netherlands)
to ensure accuracy. Haematocrits were determined by
centrifugation in capillary tubes (Hematospin 1300,
Hawksley and Sons Ltd). In addition, the clinical team
recorded the pack identifier numbers, the pack type as
issued by the transfusion laboratories (whole blood,
packed cells or RCC), the blood volume, calculated as the
weight of the pack minus the weight of the pack type
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containing no donor blood, and the date of collection
from the donor (in order to calculate storage age). Prior
to the start of the trial, we conducted training sessions on
procedures for collecting this information. We conducted
three audits examining donor blood data during the trial:
(1) at the beginning of the trial during September 2014–
January 2015 (Audit 1); (2) following a period of consul-
tation with the BTS (February–May 2015; Audit 2); and
(3) following a period of re-training during June 2015–
January 2016 (Audit 3). The duration of storage of donor
blood before transfusion was categorized as short
(≤14 days), long (15-42 days) or expired (>35 days for
whole blood and >42 days for RCC and packed cells) [12].
Statistical analysis
Comparison of haemoglobin and haematocrit levels for
the three pack types across the three audits was done
using Kruskal–Wallis equality-of-populations rank test
and Wilcoxon rank-sum test. All analyses were conducted
using Stata v15 (Stata Corp, Timberlake, Memphis, TN,
USA).
Results
A total of 2983 transfusion blood packs were utilized in
the trial between September 2014 and January 2016.
Through our audits, we found that three pack types pro-
duced by local BTS were supplied for use in the trial: (1)
whole blood, collected from donors and stored without
any preparation; (2) packed cells, produced by
centrifugation, to removal platelets and plasma, followed
by the addition of sodium, adenine, glucose and mannitol
(SAGM) solution; and (3) ‘red cell concentrates’ (RCCs),
which were supplied in Uganda only. RCCs were produced
by gravity-dependent sedimentation as an alternative to
centrifugation because of limited capacity for mechanical
separation. The process of gravity-dependent sedimenta-
tion involved packs being hung at room temperature
overnight before plasma was decanted off and SAGM
added in a closed system of bags. On the basis of the
preparation methods used, packed cells should evidently
be the most concentrated followed by RCCs and then
whole blood (Fig. 1). The overall distribution of whole
blood, packed cells and RCCs included in our three audits
was 407% (N = 1215), 224% (N = 669) and 368%
(N = 1099), respectively. The first, second and third audit
included 330, 606 and 2047 packs, respectively. Hae-
moglobin and haematocrit values were available for 2970
and 2737 donor packs, respectively.
Haematological quality of donor blood
First audit
In the first audit which was undertaken in Uganda only,
we found statistically significant (not explained by
chance alone) but only moderate differences of haemato-
logical values between the pack types. The median hae-
moglobin level was 164 g/dl (IQR: 140, 188; N = 130)
in whole blood packs, 173 g/dl (154, 194; N = 136,
P < 0001 vs. whole blood) in RCC and 189 g/dl (173,
206; N = 62; P = 0025) in packed-cell packs. Moreover,
Fig. 1 Summary of the blood preparation process and expected haemoglobin and haematocrit values. [Colour ﬁgure can be viewed at wileyonlinelibrary.
com]
© 2019 The Authors.
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we found no significant differences between pack types
in terms of haematocrit values, the medians being
570% (500, 740), 640% (520, 725; P = 0238) and
560% (480, 670; P = 0462) in whole blood, RCC and
packed cells, respectively (Table 1 and Fig. 2a). Median
haemoglobin and haematocrits values for the whole
blood packs were also substantially higher than the
expected values of 12 g/dl and 35–45% respectively.
Conversely, the medians were lower than those expected
(20 g/dl and 55–57% respectively) among packed cell
donations (Fig. 1)[14].
Quality assurance of research methods
Because these results were unexpected, we were con-
cerned that there may have been a methodological flaw
in our sampling technique. To better understand the lack
the expected differences between the three pack types in
terms of their haematological indices, we re-checked the
methods of sample collection, the reliability of our hae-
moglobin and haematocrit readings and the way in which
the pack types were labelled by the BTS. In a sample of
10 donor packs from each of the three Ugandan study
centres, we audited the measurement of haemoglobin and
haematocrit values against values from automated blood
analysers. For sample collection, we compared these mea-
surements in samples of donor blood collected in the pre-
scribed manner (at the point of exit from the giving set)
to samples collected from the top of the burette. Neither
assay method nor sampling point suggested any method-
ological explanations for the observed lack of clear
haematological differences between donor pack types
(Table S1). Consultation with the BTS centres suggested a
low emphasis on providing clear labelling instructions for
clinicians regarding the pack types. This lead to a subse-
quent change in pack labelling and our realization of the
need for a series of training sessions for BTS and blood
bank staff and clinicians (including trial staff) on the
importance of pack type identification and labelling.
Second and third audits
Audit 2, conducted after a period of intense training,
included 606 donor packs while Audit 3 involved 2047
donor packs. In both these subsequent audits, we found
clear and significant differences between the three pack
types in terms of haemoglobin and haematocrit (Table 1
and Fig. 3a,b) and between countries (Table 2). Linear
regression analysis showed a clear relationship between
pack type and both haemoglobin and haematocrit values in
which, as originally expected, the lowest values were seen
in whole blood and the highest in packed cells (Fig. 2b,c).
Only 55% (N = 164) of the packs had haemoglobin con-
centrations that were out of range (two standard deviations
above or below the mean for each of the pack types).
Storage time
Data on the age (or storage time) for 2964 donor packs
were collected prospectively throughout the TRACT trial.
Storage time was highly heterogeneous, with the median
age of transfused blood being 12 days (IQR: 6, 19) and a
range of 0–77 days. Overall, 182% (N = 537) of the
blood used in the trial was classified as old (above
21 days of age, Table 3). The median age of blood before
training (Audit 1) was 15 (IQR: 10–21) days and after
training (Audits 2 & 3) was 11 (IQR: 6–18) days
(P < 0001). Through our audits, we demonstrated that 9
(28%) blood packs used earlier in the trial (Audit 1) were
issued past the recommended duration of storage. This
proportion reduced to 10% (N = 6) and 03% (N = 7) in
the Audits 2 and 3, respectively.
Discussion
One of the key findings of this study was that, unexpect-
edly, despite US President’s Emergency Plan for AIDS
Relief (PEPFAR) strengthening of the Ugandan BTS which
included the introduction of prepared RCC, Audit 1
demonstrated negligible differences in haematological
Table 1 Summary of median (IQR) haemoglobin and haematocrit in the three audits
Pack type Expected values N Audit 1 P * N Audit 2 P * N Audit 3 P *
Hb (g/dL) WB 12 130 164 (140, 188) <0001 132 142 (130, 161) <0001 948 137 (125, 153) <0001
RCC 15 136 173 (154, 194) 361 172 (155 189) 600 165 (147, 184)
PC 20 62 189 (173, 206) 110 195 (180, 212) 491 197 (178, 212)
HCT (%) WB 35–45 111 570 (500, 740) 0271 127 420 (400, 470) <0001 912 410 (370, 490) <0001
RCC 50–70 124 640 (530, 725) 309 509 (450, 553) 564 530 (450, 610)
PC 55–75 19 560 (480, 670) 91 580 (530, 620) 481 610 (560, 660)
B, whole blood; PC, packed cell; RCC, red cell concentrates.
*P Kruskal–Wallis equality-of-populations rank test.
© 2019 The Authors.
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Fig. 2 Scatter plots of haemoglobin and haematocrit values for the blood packs used at start of the trial (a), during the training period (b) and post-
training (c). [Colour ﬁgure can be viewed at wileyonlinelibrary.com]
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indices between the three pack types. Suboptimal pack
labelling in Uganda resulted in the early part of the trial
having some inadvertent non-adherence to ‘blood vol-
ume’ (a proxy for red call mass) randomisation strategies.
Reviewing all prescribed packs, and identifying the cor-
rect pack type as opposed to what the clinician had inad-
vertently believed had been provided, during the first
4 months of the trial, non-adherence to randomised
transfusion volume was approximately 77% following the
protocol, although at the time of the transfusion
clinicians’ prescriptions were correct for the blood volume
based on what they understood had been provided. Since
then we observed improvement in protocol adherence fol-
lowing training with non-adherence to randomised blood
volumes between February and May 2015 reduced to 7%.
A second finding during the initial audit period was that
28% of blood prescribed had exceeded its recommended
storage period. Consultation between the BTS and clinical
teams lead to changes to standard operating procedures
used by the BTSs and hospital transfusion laboratories was
0
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Fig. 3 Box plots of haematocrit (a) and haemoglobin (b) before (Sep 2014–Jan 2015) and after training (Feb 2015–Jul 2016) by pack type. PC, packed
cells; RCC, red cell concentrates and WB, whole blood). *P < 005, ** P < 0001.
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subsequently implemented. This resulted in improved qual-
ity of blood. As evidenced by subsequent audits, we were
able to demonstrate significant difference in haemoglobin
and haematocrit of the three pack types after the consulta-
tion and training and the proportion of ‘expired blood’ used
by the clinical teams was also significantly reduced.
For more than a decade, driven by safety concerns that
blood transfusions may have been a factor in HIV trans-
mission, multilateral donors including PEPFAR have pro-
vided technical and financial support to national BTS in
low-income countries in sSA, with a view to improving
the quality-assured screening of all donated blood for
transfusion-transmissible infections. This has greatly
increased blood supply and reduced transfusion-transmis-
sible infections, as previously reported [15, 16]. However,
the implementation of such recommendations has also
resulted in the adoption in these countries of BTS prac-
tices and policies from high-income countries, including
the centralization of BTSs and the preparation of compo-
nents in place of the use of whole blood. Concerns have
been raised that centralization may adversely impact on
the equitable and timely access to blood transfusion [17].
Moreover, component preparation policies are costly and
time-consuming and result in delays between collection
from donors and supply to local blood banks, thus
increasing the storage times of blood. Finally, although
there appears to be a mismatch between transfusion
guidelines incorporating recommendations for standard
volumes of whole blood and packed cells (median donor
haemoglobin ~20 g/dl), the same does not seem to be true
but for RCCs (median donor haemoglobin ~15 g/dl) which
in some countries are the largest proportion of donor
blood pack now being issued from PEPFAR-compliant
BTSs. This inconsistency between guidelines and donor
packs in use has implications for the volume and number
of packs of blood required to achieve a similar degree of
haemoglobin correction in a recipient and might therefore
impact on clinical outcomes, including survival. In the
case of paediatric transfusion, WHO recommends a stan-
dard volume for transfusion (20 mls/kg of whole blood or
10 mls/kg of packed cells) for all children with profound
(Hb < 4/g/dl) or severe and complicated (Hb < 6/g/dl plus
one or more severity features) anaemia, but gives no
guidelines for RCCs. Thus, the increasing production of
RCCs by BTSs may result in many children being initially
under-transfused, increasing the need for re-transfusion,
an issue observed in a previous study [18]. Worldwide
there is little evidence to support the exclusive use of red
cell concentrates, which in our experience were a third of
blood packs issued by BTS. Most blood products used
in hospitals in Africa are generally for emergency trans-
fusion [19], to replacing lost volume (pregnancy-related
Table 2 Summary of median (IQR) haemoglobin (g/dl) and haematocrit (%) in audits 2 and 6 stratiﬁed by country
Pack type N Audit 2 Haemoglobin P * N Audit 3 Haemoglobin P *
Whole blood Malawi 71 137 (128, 145) <0001 395 135 (126, 143) <0001
Uganda 62 152 (136, 174) 553 141 (124, 165)
Packed cells Malawi 10 192 (172, 199) 0333 83 206 (189, 215) 0003
Uganda 100 195 (180, 212) 408 194 (177, 211)
Pack type N Audit 2 Haematocrit P * N Audit 3 Haematocrit P *
Whole blood Malawi 73 410 (380, 470) <0001 386 390 (360, 410) <0001
Uganda 54 471 (420, 550) 526 460 (400, 570)
Packed cells Malawi 9 550 (490, 570) 0101 79 560 (530, 590) <0001
Uganda 82 590 (541, 620) 402 620 (575, 680)
*P – Wilcoxon rank-sum test for comparison by pack type between the two countries.
Table 3 Storage duration proﬁles of blood packs used in the trial
Duration of storage Audit 1 Audit 2 Audit 3 Total
Short (0–14 days) 99 (305) 162 (269) 940 (461) 960 (405)
Long (15–42 days) 216 (667) 435 (721) 1092 (536) 1733 (588)
Expired* 9 (28) 6 (10) 7 (03) 22 (07)
Total 324 603 2039 2956
N (%).
*Expired (>35 days for whole blood and >42 days for red cell concentrates and packed cells).
© 2019 The Authors.
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emergencies) and trauma or paediatric transfusion for
life-threatening anaemia, for which paediatric guidelines
suggest are better treated with whole blood than blood
components [17, 20].
Numerous challenges face BTS in sSA, including lack of
adequate finance; adequate infrastructure; safe blood
donors; unbroken supply of consumables and reagents,
limited man-power to process collected blood, stock outs of
screening reagents, lack of transport for transportation of
packs to regional blood banks and regular power-outages.
Such challenges threaten the safe preparation of RCCs by
gravity-dependent sedimentation, and also result in subop-
timal storage conditions. Moreover, processing at regional
BTS leads to delays between donation, processing and dis-
tribution across the regional hospital services which can
contribute to prolonged storage times. Prior to the trial
beginning, we believed that pressure from demand would
mean that ‘old blood’ would be rare. Instead, we found that
the age of blood supplied during TRACT was quite diverse,
and included some packs that should have been discarded
as they were ‘expired’. Prolonged storage may result in
adverse consequences owing to red cell changes (the stor-
age lesion) that may render them less effective as oxygen
carriers and lead to an accumulation of metabolites and
cytokines that may lead to untoward side effects [21, 22].
The TOTAL trial, conducted in 270 Uganda children investi-
gated whether leucocyte-reduced RCCs stored for 25–
35 days lead to worse outcomes than packs stored for 10 or
less days. Lactate clearance, the primary endpoint, was not
inferior in those receiving prolonged compare to short stor-
age donor blood, as were all other secondary endpoints
including mortality [23]. Educating both BTS staff and
clinicians to not issue or use blood transfusions that have
gone beyond their expiry date is clearly important. In this
respect, it is also worth noting that in the African health
system, there is little formal training of clinicians in
haemovigilance and there are no reporting systems similar
to the SHOT (serious hazards of transfusion) scheme in the
UK [24]. Thus, despite being a major issue for research in
other parts of the world, there remains uncertainty over
whether prolonged storage of non-leucocyte reduced blood
under standard storage conditions impacts on patient out-
come in SSA.
Finally, it is important to point out that donated blood
issued for transfusion by BTSs or hospitals blood banks
in sSA is likely to have several differences compared with
high-income countries. Beyond the issues of quality
assurance and lack of leucocyte depletion are the genetic
diversity of donors, as many have inherited red cell disor-
ders (including a-thalassaemia, sickle cell trait and glu-
cose-6-phosphate dehydrogenase deficiency) [25, 26], all
of which are associated with shorter red cell half-lives. As
a result, this requires locally generated research studies to
help African health services refine their blood donation
practices and policies. We suggest that the findings of our
first audit reflect the reality of paediatric transfusion
across similar settings that have transitioned from the
exclusive use of whole blood to include a majority of
packs prepared as RCCs, which are not currently recog-
nized in treatment guidelines, nor has there been a con-
certed effort to inform clinicians about how this may
affect transfusion practice.
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Supporting Information
Additional Supporting Information may be found in the online version of this article:
Table S1 Comparison of sample collection and analysis methods at three TRACT trial sites in Uganda.
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